Literature DB >> 30243415

Variations in prescription drug monitoring program use by prescriber specialty.

Benjamin C Sun1, Nicoleta Lupulescu-Mann2, Christina J Charlesworth2, Hyunjee Kim2, Daniel M Hartung3, Richard A Deyo4, K John McConnell5.   

Abstract

BACKGROUND: Although prescription drug monitoring programs (PDMPs) have been widely implemented to potentially reduce abuse of prescription opioids, there is limited data on variations in PDMP use by prescriber specialty. Such knowledge may guide targeted interventions to improve PDMP use.
METHODS: Using data from Washington state Medicaid program, we performed a retrospective cohort study of opioid prescribers and their PDMP queries between Nov 1, 2013 and Oct 31, 2014. PDMP registration was mandatory for emergency physicians, but not for other providers. The unit of analysis was the prescriber. The primary outcome was any prescriber queries of the PDMP. We used multivariate regression models to identify variations in PDMP queries by prescriber specialty, as well as to explore explanatory pathways for observed variations.
RESULTS: We studied 17,390 providers who prescribed opioids, including 8718 (50%) who were not registered with PDMP, 4767 (27%) who were registered but had no recorded use of the PDMP, and 3905 (23%) PDMP users (queries/user: median 18, IQR 5-64). Compared to general medicine physicians, PDMP use was higher for emergency physicians (OR 1.4, 95%CI: 1.2-1.7), and lower for surgical specialists (OR 0.1, 95%CI: 0.08-0.1), obstetrician-gynecologists (OR 0.2, 95%CI: 0.1-0.2) and dentists (OR 0.4, 95%CI: 0.4-0.5). Higher use by emergency physicians appeared to be mediated by higher registration rates, rather than by provider level predilection to use the PDMP.
CONCLUSIONS: A minority of opioid prescribers to Medicaid beneficiaries used the PDMP. We identified variations in PDMP use by prescriber specialty. Interventions to increase PDMP queries should target both PDMP registration and PDMP use after registration, as well as specialties with current low use rates.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Prescription drug monitoring program

Mesh:

Substances:

Year:  2018        PMID: 30243415      PMCID: PMC6453570          DOI: 10.1016/j.jsat.2018.08.006

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  27 in total

1.  Can prescription drug monitoring programs help limit opioid abuse?

Authors:  Hallam M Gugelmann; Jeanmarie Perrone
Journal:  JAMA       Date:  2011-11-23       Impact factor: 56.272

2.  Impact of New York prescription drug monitoring program, I-STOP, on statewide overdose morbidity.

Authors:  Richard Brown; Moira R Riley; Lydia Ulrich; Ellen Percy Kraly; Paul Jenkins; Nicole L Krupa; Anne Gadomski
Journal:  Drug Alcohol Depend       Date:  2017-06-23       Impact factor: 4.492

3.  Prevention of prescription opioid abuse: the role of the dentist.

Authors:  Richard C Denisco; George A Kenna; Michael G O'Neil; Ronald J Kulich; Paul A Moore; William T Kane; Noshir R Mehta; Elliot V Hersh; Nathaniel P Katz
Journal:  J Am Dent Assoc       Date:  2011-07       Impact factor: 3.634

4.  Impact of Hospital "Best Practice" Mandates on Prescription Opioid Dispensing After an Emergency Department Visit.

Authors:  Benjamin C Sun; Nicoleta Lupulescu-Mann; Christina J Charlesworth; Hyunjee Kim; Daniel M Hartung; Richard A Deyo; K John McConnell
Journal:  Acad Emerg Med       Date:  2017-07-26       Impact factor: 3.451

5.  Best Practices for Prescription Drug Monitoring Programs in the Emergency Department Setting: Results of an Expert Panel.

Authors:  Margaret B Greenwood-Ericksen; Sabrina J Poon; Lewis S Nelson; Scott G Weiner; Jeremiah D Schuur
Journal:  Ann Emerg Med       Date:  2015-11-25       Impact factor: 5.721

6.  Usability of the Massachusetts Prescription Drug Monitoring Program in the Emergency Department: A Mixed-methods Study.

Authors:  Sabrina J Poon; Margaret B Greenwood-Ericksen; Rebecca E Gish; Pamela M Neri; Sukhjit S Takhar; Scott G Weiner; Jeremiah D Schuur; Adam B Landman
Journal:  Acad Emerg Med       Date:  2016-03-26       Impact factor: 3.451

7.  Effect of Automated Prescription Drug Monitoring Program Queries on Emergency Department Opioid Prescribing.

Authors:  Benjamin C Sun; Christina J Charlesworth; Nicoleta Lupulescu-Mann; Jenny I Young; Hyunjee Kim; Daniel M Hartung; Richard A Deyo; K John McConnell
Journal:  Ann Emerg Med       Date:  2017-12-13       Impact factor: 5.721

8.  Association of Prescription Drug Monitoring Program Use With Opioid Prescribing and Health Outcomes: A Comparison of Program Users and Nonusers.

Authors:  Richard A Deyo; Sara E Hallvik; Christi Hildebran; Miguel Marino; Rachel Springer; Jessica M Irvine; Nicole O'Kane; Joshua Van Otterloo; Dagan A Wright; Gillian Leichtling; Lisa M Millet; Jody Carson; Wayne Wakeland; Dennis McCarty
Journal:  J Pain       Date:  2017-10-18       Impact factor: 5.820

9.  The current utilization and perceptions of prescription drug monitoring programs among emergency medicine providers in Florida.

Authors:  Henry W Young; Joseph A Tyndall; Linda B Cottler
Journal:  Int J Emerg Med       Date:  2017-04-18

10.  Overdose Deaths Involving Opioids, Cocaine, and Psychostimulants - United States, 2015-2016.

Authors:  Puja Seth; Lawrence Scholl; Rose A Rudd; Sarah Bacon
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2018-03-30       Impact factor: 17.586

View more
  10 in total

1.  Comparing Changes in Controlled Substance Prescribing Trends by Provider Type.

Authors:  Amy L Meadows; Justin C Strickland; Shiraz Qalbani; Kailyn L Conner; Amanda Su; Craig R Rush
Journal:  Am J Addict       Date:  2019-10-10

2.  Advanced visualizations to interpret prescription drug monitoring program information.

Authors:  Scott G Weiner; Karen M Sherritt; Zoe Tseng; Jaya Tripathi
Journal:  Drug Alcohol Depend       Date:  2019-06-25       Impact factor: 4.492

3.  Association of opioid exposure before surgery with opioid consumption after surgery.

Authors:  Mark C Bicket; Vidhya Gunaseelan; Pooja Lagisetty; Anne C Fernandez; Amy Bohnert; Elizabeth Assenmacher; Melwyn Sequeira; Michael J Englesbe; Chad M Brummett; Jennifer F Waljee
Journal:  Reg Anesth Pain Med       Date:  2022-03-03       Impact factor: 5.564

4.  "1,000 conversations I'd rather have than that one:" A qualitative study of prescriber experiences with opioids and the impact of a prescription drug monitoring program.

Authors:  Jillian Zavodnick; Alexis Wickersham; Alison Petok; Brooke Worster; Amy Leader
Journal:  J Addict Dis       Date:  2022-02-08

5.  Academic detailing increases prescription drug monitoring program use among primary care practices.

Authors:  Sarah J Ball; Jenna A McCauley; Megan Pruitt; Jingwen Zhang; Justin Marsden; Kelly S Barth; Patrick D Mauldin; Mulugeta Gebregziabher; William P Moran
Journal:  J Am Pharm Assoc (2003)       Date:  2021-03-03

6.  Advances in prescription drug monitoring program research: a literature synthesis (June 2018 to December 2019).

Authors:  Chris Delcher; Nathan Pauly; Patience Moyo
Journal:  Curr Opin Psychiatry       Date:  2020-07       Impact factor: 4.787

7.  Obstetrician-gynecologist perceptions and utilization of prescription drug monitoring programs: A survey study.

Authors:  Amie Goodin; Jungjun Bae; Chris Delcher; Joshua Brown; Dikea Roussos-Ross
Journal:  Medicine (Baltimore)       Date:  2021-01-08       Impact factor: 1.817

8.  Health Care Provider Utilization of Prescription Monitoring Programs: A Systematic Review and Meta-Analysis.

Authors:  Alysia Robinson; Maria N Wilson; Jill A Hayden; Emily Rhodes; Samuel Campbell; Peter MacDougall; Mark Asbridge
Journal:  Pain Med       Date:  2021-07-25       Impact factor: 3.750

Review 9.  Optimization of Prescription Drug Monitoring Program to Overcome Opioid Epidemic in West Virginia.

Authors:  Ala-Eddin Yassin Al-Astal; Komal Sodhi; Hari Vishal Lakhani
Journal:  Cureus       Date:  2022-02-21

10.  Predicting the Physician's Specialty Using a Medical Prescription Database.

Authors:  Mahboube Akhlaghi; Hamed Tabesh; Behzad Mahaki; Mohammad-Reza Malekpour; Erfan Ghasemi; Marjan Mansourian
Journal:  Comput Math Methods Med       Date:  2022-09-16       Impact factor: 2.809

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.